Press Releases | BioSenic

Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2016

Read more about Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2016

Bone Therapeutics extends Kasios collaboration

Read more about Bone Therapeutics extends Kasios collaboration

Bone Therapeutics treats 12 patients without safety concerns in ALLOB® Phase IIA spinal fusion trial

Read more about Bone Therapeutics treats 12 patients without safety concerns in ALLOB® Phase IIA spinal fusion trial

Bone Therapeutics Provides Business Update for the Fourth Quarter of 2015

Read more about Bone Therapeutics Provides Business Update for the Fourth Quarter of 2015

Bone Therapeutics presents ALLOB® pre-clinical and early clinical efficacy data in spinal fusion at the Clinical Applications of Stem Cells Conference

Read more about Bone Therapeutics presents ALLOB® pre-clinical and early clinical efficacy data in spinal fusion at the Clinical Applications of Stem Cells Conference

Bone Therapeutics Notice of Full Year 2015 Results: Results to be announced on 29 March 2016

Read more about Bone Therapeutics Notice of Full Year 2015 Results: Results to be announced on 29 March 2016

Bone Therapeutics reports initial efficacy results from its PREOB® Phase IIA trial in severe osteoporosis

Read more about Bone Therapeutics reports initial efficacy results from its PREOB® Phase IIA trial in severe osteoporosis

Bone Therapeutics Reports Full Year 2015 Results

Read more about Bone Therapeutics Reports Full Year 2015 Results

Bone Therapeutics announces the publication of its Annual Report 2015

Read more about Bone Therapeutics announces the publication of its Annual Report 2015

The preliminary documents for the Annual General Shareholder Meeting on 26 May 2016 have been made available

Read more about The preliminary documents for the Annual General Shareholder Meeting on 26 May 2016 have been made available

Subscribe to Press Releases